0001562180-24-001985.txt : 20240229
0001562180-24-001985.hdr.sgml : 20240229
20240229163326
ACCESSION NUMBER: 0001562180-24-001985
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leupin Nicolas
CENTRAL INDEX KEY: 0002007766
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 24704336
MAIL ADDRESS:
STREET 1: BUSINESS VILLAGE D4
STREET 2: PARK 6/PLATZ 10
CITY: ROOT
STATE: V8
ZIP: 6039
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-02-27
false
0001645113
NovoCure Ltd
NVCR
0002007766
Leupin Nicolas
C/O NOVOCURE INC.
1550 LIBERTY RIDGE DRIVE, SUITE 115
WAYNE
PA
19087
false
true
false
false
Chief Medical Officer
false
Ordinary Shares
2024-02-27
4
A
false
51124.00
16.30
A
51124.00
D
Stock Options (Right to buy)
16.30
2024-02-27
4
A
false
78174.00
16.30
A
2025-02-27
2034-02-26
Ordinary Shares
78174.00
78174.00
D
Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
Options to buy 78,174 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
Steven Robbins, as attorney in fact for Leupin, Nicolas
2024-02-29
EX-24
2
poa-ex24_leupin.txt
EX-24 POA - NICOLAS LEUPIN
LIMITED POWER OF ATTORNEY
FOR
SECTION 16 REPORTING PURPOSES
Know all by these presents, that the
undersigned hereby makes, constitutes and
appoints Barak Ben-Arye, Steven Robbins,
Ovie Onobrakpeya and Carrie Kane,
individually, as the undersigned's true and
lawful attorneys-in-fact, with full power and
authority as hereinafter described on behalf
of and in the name, place and stead of the
undersigned to:
(1) execute for, and on behalf of, the
undersigned, in the undersigned's capacity
as an officer, director and/or 10% beneficial
owner of Novocure Limited (the
"Company"), Forms 3, 4, and 5 in
accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the
rules and regulations promulgated
thereunder (the "Exchange Act");
(2) seek or obtain, as the undersigned's
representative and on the undersigned's
behalf, information on transactions in the
Company's securities from any third party,
including brokers, employee benefit plan
administrators and trustees, and the
undersigned hereby authorizes any such
person to release any such information to
any attorneys-in-fact and further approves
and ratifies any such release of information;
(3) do and perform any and all acts for
and on behalf of the undersigned that may
be necessary or desirable to prepare,
complete and execute any such Form 3, 4 or
5, and any amendments thereto, or other
required report and timely file such Forms
or reports with the United States Securities
and Exchange Commission, the New York
Stock Exchange and any stock exchange or
similar authority as considered necessary or
advisable under Section 16(a) of the
Exchange Act; and
(4) take any other action of any type
whatsoever in connection with the foregoing
which, in the opinion of such attorneys-in-
fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it
being understood that the documents
executed by such attorneys-in-fact on behalf
of the undersigned pursuant to this Limited
Power of Attorney shall be in such form and
shall contain such terms and conditions as
such attorneys-in-fact may approve in such
attorney-in-fact's sole discretion.
The undersigned hereby gives and grants to
each such attorneys-in-fact full power and
authority to do and perform any and every
act and thing whatsoever requisite,
necessary, or proper to be done in the
exercise of any of the rights and powers
herein granted, as fully to all intents and
purposes as the undersigned might or could
do if personally present, with full power of
substitution or revocation, hereby ratifying
and confirming all that such attorneys-in-
fact, or such attorneys-in-fact's substitute or
substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and
the rights and powers herein granted.
The undersigned hereby acknowledges that
(a) the foregoing attorneys-in-fact are
serving in such capacity at the request of the
undersigned; (b) this Limited Power of
Attorney authorizes, but does not require,
each such attorneys-in-fact to act in his or
her discretion on information provided to
such attorneys-in-fact without independent
verification of such information; (c) any
documents prepared and/or executed by any
attorneys-in-fact on behalf of the
undersigned pursuant to this Limited Power
of Attorney shall be in such form and shall
contain such information and disclosure as
such attorneys-in-fact, in his or her sole
discretion, deems necessary or advisable; (d)
neither the Company nor any attorneys-in-
fact assumes (i) any liability for the
undersigned's responsibility to comply with
the requirements of the Exchange Act,
(ii) any liability of the undersigned for any
failure to comply with such requirements or
(iii) any obligation or liability of the
undersigned for profit disgorgement under
Section 16(b) of the Exchange Act; and (e)
this Limited Power of Attorney does not
relieve the undersigned from responsibility
for compliance with the undersigned's
obligations under the Exchange Act,
including, without limitation, the reporting
requirements under Section 16 of the
Exchange Act.
This Limited Power of Attorney shall
remain in full force and effect until the
undersigned is no longer required to file
Forms 3, 4, and 5 with respect to the
undersigned's holdings of, and transactions
in, securities issued by the Company, unless
earlier revoked as to any attorneys-in-fact by
the undersigned in a signed writing
delivered to such attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned
has caused this Power of Attorney to be
executed as of this 4th day of January,
2024.
/s/ Nicolas Leupin
Signature
Nicolas Leupin
Print Name